Compare Enzyme (MLN) vs SUPRA (SUPRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs SUPRA — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while SUPRA trades at Rp2.91 (market cap Rp97,11M, Rp5,21M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and SUPRA's supply is capped (32,7B / 100B SUPRA (33%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and SUPRA for 17 Days on average.
| MLN | SUPRA | |
|---|---|---|
Market Cap | Rp134,13M | Rp97,11M |
Volume (24h) | Rp104,56M | Rp5,21M |
Circulating Supply | 3,3M MLN | 32,7B / 100B SUPRA (33%) |
Typical Hold Time | 29 Days | 17 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
SUPRA is currently trading at Rp3.006 with a market cap of Rp98.21 million, exhibiting a strong bearish technical signal across moving averages and oscillators. The token's circulation rate is 33%, with an average hold time of 17 days. Current technical indicators show RSI levels in the oversold territory, suggesting potential for a short-term bounce, while ADX readings indicate a strong downtrend. No major protocol updates or ecosystem developments were identified in recent research.
The overall outlook remains cautious due to prevailing bearish momentum and limited fundamental catalysts. Key opportunities include potential oversold rebounds, while major risks involve low liquidity, high volatility, and the token's relatively small market capitalization making it susceptible to price swings. Investors should monitor for any significant ecosystem developments or changes in market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About SUPRA
Supra is the first blockchain built for Automatic DeFi (AutoFi), an automated financial system. As a Layer-1 solution, it supports high-speed smart contracts with integrated data and AI oracles, automation, and cross-chain messaging. This allows for innovative AutoFi features that generate revenue and redistribute it to applications and node operators, reducing reliance on block rewards over time. The Supra stack also provides AI agents with the tools needed to create and execute effective AutoFi strategies for users in a fully on-chain, secure, and autonomous manner.
Read more on SUPRA →
